| | |||||
| Ebola | |||||
| NEWS | |||||
| NantKwest Inc. (NK)'s Financial Results Comparing With Novavax Inc. (NASDAQ:NVAX) It also develops Ebola GP vaccine in Phase 1 clinical trial; preclinical programs for Zika virus; and seasonal influenza and a combination respiratory ...
| |||||
| See more results | Edit this alert | |||||
| You have received this email because you have subscribed to Google Alerts. |
Receive this alert as RSS feed |
| Send Feedback |
Tidak ada komentar:
Posting Komentar